More features – Page 48
-
Feature
On the hunt for a blockbuster
Swiss biopharmaceutical company Actelion had a good financial year in 2005 and is now hoping for a drug to take it to the next level of success. Katharine Sanderson reports
-
Feature
The expanding world of microarrays
DNA microarrays play a major role in gene expression research and now second generations of the technology are coming into play. Michael Gross reports
-
Feature
Attracting bioscience
Singapore has succeeded in developing itself as a hub for biomedical research and manufacturing. Mark Whitfield explores the sector
-
Feature
Extreme crystallography
Scientists at the Centre for Science at Extreme Conditions in Edinburgh, UK, are subjecting crystals to immense pressures, with surprising results. Simon Hadlington reports
-
FeatureLSD: cultural revolution and medical advances
Albert Hofmann has largely faded from public view but his creation has become part of our cultural fabric. David Nichols reports
-
Feature
2005: a year in perspective
As 2005 draws to a close, Bea Perks and Katharine Sanderson highlight the main issues that affected the chemical science community, as reported in Chemistry World
-
FeatureExplosive science
New and improved explosives detectors are bringing hope to the war against terror and helping the search for unexploded landmines, as Gaetano Mancino reports
-
Feature
The Sanger success story
Double Nobel prize-winner Fred Sanger recalls his days in the lab, attributing his success to the time he spent at the bench. Emma Davies reports
-
Feature
Uncorking wine's characteristics
Chemicals are responsible for the flavour and bouquet of wine. Could understanding the chemistry help you pick the ideal tipple for your Christmas dinner? Katie Gibb investigates
-
Feature
Putting the nano into nanotechnology
The discovery of a new form of elemental carbon 20 years ago changed thinking in chemistry. Philip Ball investigates whether the buckyball has lived up to the hype and what legacy it has left
-
Feature
Gunpowder, treason and plot
November 2005 saw the 400th anniversary of the gunpowder plot. Each year we celebrate the fact that the plot was foiled but it now seems unlikely that the gunpowder would have ignited, as Katharine Sanderson finds out
-
Feature
Where biology meets chemistry
Material scientists are taking a leaf out of nature's book in the hunt for new products. Michael Gross investigates
-
Feature
Finland: passionate about innovation
Finland's bioscience industry is flourishing, thanks to the country's competitive environment and heavy investment in R&D, as Helen Carmichael finds out.
-
FeatureThree share prize for metathesis work
The discoveries made by this year's Nobel laureates have had a great impact on new drug developments, polymeric materials and industrial syntheses. Karen Harries-Rees reports.
-
Feature
A changing landscape
Forecasts predict that oil prices will remain high. This could have a major impact on the structure and economics of the petrochemical industry. Sean Milmo reports
-
Feature
Preparing for a sustainable future
Sustainable production is a global business and products must comply with legislation in several countries. Bea Perks looks at the different approaches in the UK, Japan, China and the US
-
Feature
Green tea: the great healer
Green tea promises to cure many of our ills but does it live up to expectations? Andrew Scott looks at the chemistry behind the health claims
-
Feature
Two become one
Katharine Sanderson finds out about the merger of two companies and the birth of a new business, GE Healthcare, which aims to provide complete medical imaging and personalised healthcare solutions
-
Feature
A challenging toxic legacy
Iraq's natural environment is in a dire state, but the security situation is seriously hampering the clean-up operation, as Simon Hadlington reports
-
Feature
Battle with the prions
Prion diseases such as Creutzfeldt-Jakob are invariably fatal. But, as Dennis Rouvray reports, better insights into the protein chemistry involved are leading to new therapies